CRL vs RDIB · rev $2.00B vs rev $112.0M
Charles River Laboratories (CRL) versus Reading International B Inc (RDIB) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Reading International B Inc (RDIB) is a entertainment company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported RDIB revenue for 2026-06-30 was $112.0M. Net income was -$5.9M. RDIB currently screens at market cap $211.3M.
CRL currently screens at market cap $7.78B. RDIB currently screens at market cap $211.3M.
Not investment advice. Open the CRL and RDIB stock pages for the full models.
Not investment advice.